<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01543256</url>
  </required_header>
  <id_info>
    <org_study_id>CDM00047682</org_study_id>
    <nct_id>NCT01543256</nct_id>
  </id_info>
  <brief_title>WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study</brief_title>
  <official_title>A Multi-Center, Prospective, Randomized Study Comparing Removable, Self-Expanding Metal Stents to Plastic Stents for the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this of this study is to compare the use of Self Expanding Metal Stents (SEMS)
      to plastic stents for the treatment of benign biliary strictures secondary to chronic
      pancreatitis as it pertains to stricture resolution rates, complication rates and number of
      ERCP procedures during 24 months.

      Statistical testing will be performed to determine if the rate of stricture resolution for
      the metal stent is non-inferior to the plastic stent group.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 2012</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stricture resolution</measure>
    <time_frame>24 months</time_frame>
    <description>To determine if the rate of stricture resolution for the metal stent is non-inferior to the plastic stent group. The null hypothesis is that the stricture resolution rate is non-inferior in the Metal Stent Arm versus the Plastic Stent Arm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of adverse events related to the stent and/or the stent placement or removal procedures.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of ERCP procedures through 24 months after initial stent placement.</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to deploy the stent(s) in satisfactory position(technical success at placement).</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to remove the stent(s) without serious stent removal related adverse events at each procedure involving removal of stent(s).</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver Function Tests (LFT's) improvement at month 1 compared to baseline and at month 24 compared to removal of last stent (applicable for subjects who had not been re-stented at time of month 24 visit).</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economic Endpoint</measure>
    <time_frame>24 months</time_frame>
    <description>Number of outpatient procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economic Endpoint</measure>
    <time_frame>24 months</time_frame>
    <description>Number of hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economic Endpoint</measure>
    <time_frame>24 months</time_frame>
    <description>Duration of hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economic Endpoint</measure>
    <time_frame>24 months</time_frame>
    <description>Length of procedures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economic Endpoint</measure>
    <time_frame>24 months</time_frame>
    <description>Number of devices</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Biliary Stricture</condition>
  <arm_group>
    <arm_group_label>Metal stents</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The WallFlex Biliary Fully Covered Stent System is being evaluated for treatment of benign biliary strictures secondary to chronic pancreatitis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plastic Stents</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Plastic stents per Investigator preference are being evaluated for treatment of benign biliary strictures secondary to chronic pancreatitis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WallFlex™ Biliary RX Fully Covered Stent System RMV</intervention_name>
    <description>Temporary placement of the WallFlex Biliary RX Fully Covered Stent for treatment of benign biliary strictures secondary to chronic pancreatitis. The stent will be removed after 12 months indwell.</description>
    <arm_group_label>Metal stents</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Commercially available Plastic Stent Per Investigator preference</intervention_name>
    <description>Temporary placement/exchange of multiple biliary plastic stents for treatment of benign biliary strictures secondary to chronic pancreatitis. Stents will be removed after cumulative indwell of 12 months.</description>
    <arm_group_label>Plastic Stents</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Willing and able to comply with the study procedures and provide written informed
             consent to participate in the study

          -  Chronic pancreatitis

          -  Symptomatic bile duct stricture (defined by cholangitis or persistent jaundice for at
             least one month or cholestasis associated with at least 3 times normal alkaline
             phosphatase levels) documented at time of enrollment for naïve stricture or at the
             time of prior plastic stent placement in strictures that had one prior plastic stent
             inserted.12

          -  Common bile duct stricture based on imaging assessment of dilatation of the common
             and/or intrahepatic bile ducts

        Exclusion Criteria:

          -  Biliary stricture of benign etiology other than chronic pancreatitis

          -  Prior biliary metal stent or any plastic stenting other than one plastic stent of 10
             Fr or less for 6 months or fewer

          -  Developing obstructive biliary symptoms associated with an attack of acute
             pancreatitis

          -  Biliary stricture of malignant etiology

          -  Stricture within 2 cm of common bile duct bifurcation

          -  Known bile duct fistula or leak

          -  Subjects for whom endoscopic techniques are contraindicated

          -  Known sensitivity to any components of the stent or delivery system

          -  Symptomatic duodenal stenosis (with gastric stasis)

          -  Participation in another investigational study within 90 days prior to consent

          -  Investigator Discretion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>D.Nageshwar Reddy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Institute of Gastroenterology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Prince Alfred Medical Center</name>
      <address>
        <city>Newtown</city>
        <state>New South Wales</state>
        <zip>2042</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus AKH</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHUM - Hopital Saint-Luc</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X 3J4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Dusseldorf</name>
      <address>
        <city>Dusseldorf</city>
        <zip>D-40217</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Shatin</city>
        <state>New Territories</state>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asian Institute of Gastroenterology</name>
      <address>
        <city>Hyderabad</city>
        <zip>500 082</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Integrata di Verona</name>
      <address>
        <city>Verona</city>
        <state>VR</state>
        <zip>37134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Agostino Gemelli</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <state>CE</state>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Universitets Sjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>S-14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>India</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 14, 2012</study_first_submitted>
  <study_first_submitted_qc>February 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2012</study_first_posted>
  <last_update_submitted>June 25, 2020</last_update_submitted>
  <last_update_submitted_qc>June 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>benign biliary strictures secondary to chronic pancreatitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

